Friday, January 6, 2017

BRIEF-FDA grants orphan drug designation to ALXN1210

* FDA grants orphan drug designation to ALXN1210 for the

treatment of patients with paroxysmal nocturnal hemoglobinuria

(pnh)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)